Filament Health

Filament Health is a global extraction and drug discovery company. The company have a deep natural psychedelics IP portfolio and are led by an accomplished botanical extraction management team.

Filament Health

The company’s aim is to make safe, natural psychedelics accessible to anyone who needs them by unlocking their healing potential through hard extraction and drug discovery science.

They possess a Health Canada psilocybin Dealer’s License as well as in-house GMP manufacturing capabilities at their R&D facility on the British Columbia Institute of Technology campus.

Filament aims to discover and extract naturally occurring psychedelic compounds and make these drugs available to people with mental disorders. At present, the company are preparing to conducted trials on their proprietary psilocybin formulation PEX010.

“Psychedelic Medicines Naturally Derived.”

On June 24th 2021, Filament Health raised a total of C$5,000,000 at Initial Public Offering (IPO) on Canadas NEO Exchange. Valuation at IPO was $60,000.


Company Information

Filament Health Website

February, 2021


B2B Manufacturing Pharmaceutical Drug Discovery

Explore more company info with a Tree membership

📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates

Explore memberships


HQ / Office 550 Burrard St #2900, Vancouver, BC V6C 0A3, Canada
Inline Feedbacks
View all comments